Ovid Therapeutics Inc. SEC filings OVID
Ovid Therapeutics Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 18, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 23, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| EFFECT | Filing | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| EFFECT | Filing | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2023 | — |
| CT ORDER | Filing | Mar 18, 2021 | — |
| EFFECT | Filing | Nov 20, 2020 | — |
| CORRESP | Letter to the SEC | Nov 18, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| EFFECT | Filing | Jun 19, 2018 | — |
| CT ORDER | Filing | Apr 19, 2018 | — |
| EFFECT | Filing | May 4, 2017 | — |
| CERTNAS | Auto-generated paper document | May 4, 2017 | — |
| CT ORDER | Filing | May 4, 2017 | — |
| 8-A12B | Filing | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 2, 2017 | — |
| CORRESP | Letter to the SEC | May 2, 2017 | — |
| CORRESP | Letter to the SEC | Apr 17, 2017 | — |
| DRSLTR | Filing | Mar 20, 2017 | — |
| DRS/A | Filing | Mar 20, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2017 | — |
| DRS | Filing | Feb 3, 2017 | — |
| D | Filing | Jan 20, 2017 | — |
| D | Filing | Aug 18, 2015 | — |
| D | Filing | Mar 18, 2015 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OVID (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1636651
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.